Simona Scarioni

ORCID: 0009-0003-0277-8051
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Influenza Virus Research Studies
  • COVID-19 and Mental Health
  • SARS-CoV-2 and COVID-19 Research
  • Diabetes and associated disorders
  • Respiratory viral infections research
  • Antibiotic Resistance in Bacteria
  • COVID-19 Clinical Research Studies
  • Vaccine Coverage and Hesitancy
  • Bacterial Identification and Susceptibility Testing
  • Pneumonia and Respiratory Infections
  • Antibiotic Use and Resistance
  • Diabetes Management and Research

University of Milan
2024-2025

To describe the trends of type 1 diabetes(T1D) incidence in 0-17-year-olds over years 2020-2023, and COVID-19 vaccination uptake Lombardy region. Data about children adolescents aged 0-17 who received a diagnosis T1D from 2020 to 2023 were extracted public computerized registry healthcare system Region (Italy). After calculating annual incidence, 2020, prior availability vaccination, was compared subsequent years. A separate analysis conducted for 12-17 age group, first receive vaccination....

10.1371/journal.pone.0316340 article EN cc-by PLoS ONE 2025-02-10

Background Respiratory syncytial virus (RSV) is a leading cause of hospitalisation in children worldwide. Recent regulatory approval monoclonal antibody (mAb) nirsevimab for infants and the RSVpreF vaccine pregnant women offers promising approaches to mitigate RSV-associated morbidity. Aim To evaluate potential impacts routine prophylactic campaigns (mAbs targeting or maternal vaccination) introduced 2024/25 season on hospitalisations from RSV lower respiratory tract infections Lombardy,...

10.2807/1560-7917.es.2025.30.14.2400637 article EN cc-by Eurosurveillance 2025-04-10

Antimicrobial resistance is a significant threat to public health, with Italy experiencing substantial challenges in terms of AMR rate, surveillance system and activities combat AMR. In response, the MICRO-BIO project was initiated as part National Plan Combat Antibiotic Resistance by Region Lombardy health department. It launched 2018 aim creating tool integrating data on bacterial isolates from microbiology laboratories. The participating laboratories were directly involved reviewing...

10.3389/fpubh.2024.1341482 article EN cc-by Frontiers in Public Health 2024-02-12

Background: Vaccination is a highly effective tool for controlling infectious diseases, particularly in populations at high risk of contagion due to clinical conditions or occupational exposure, such as healthcare workers. The purpose this study present the open day event that marked beginning influenza and anti-COVID-19 vaccination campaign Lombardy region describe experience an Istituto di Ricovero e Cura Carattere Scientifico Milan. Methods: During day, eligible individuals received free...

10.3390/ijerph21060685 article EN International Journal of Environmental Research and Public Health 2024-05-27

Abstract Context Type 1 (T1D) and type 2 diabetes (T2D) are associated with an elevated incidence of infectious diseases a higher risk infections-related hospitalization death. Objective In this study, we delineated the “vaccinome” landscape obtained large immunization schedule offered by Regional Government Lombardy in cohort 618 396 patients (T1D T2D). Methods Between September 2021 2022, coverage for influenza, meningococcus, pneumococcus, herpes zoster was from public computerized...

10.1210/clinem/dgae476 article EN publisher-specific-oa The Journal of Clinical Endocrinology & Metabolism 2024-07-20
Coming Soon ...